BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31235657)

  • 1. CD71
    Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY
    Mol Cancer Res; 2019 Sep; 17(9):1867-1880. PubMed ID: 31235657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness.
    Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY
    J Pathol; 2018 Feb; 244(2):151-163. PubMed ID: 28944962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-induced Nurr1 promotes cancer aggressiveness, self-renewal, and radioresistance via ERK and AKT signaling in cervical cancer.
    Wan PK; Leung TH; Siu MK; Mo XT; Tang HW; Chan KK; Cheung AN; Ngan HY
    Cancer Lett; 2021 Jan; 497():14-27. PubMed ID: 33010383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Targeting of HPV18 E6 and E7 Synchronously by Nonviral Transfection of CRISPR/Cas9 System in Cervical Cancer.
    Ling K; Yang L; Yang N; Chen M; Wang Y; Liang S; Li Y; Jiang L; Yan P; Liang Z
    Hum Gene Ther; 2020 Mar; 31(5-6):297-308. PubMed ID: 31989837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis.
    Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B
    Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of HPV Pseudotype Virus in Cutting E6 Gene Selectively in SiHa Cells.
    Cheng YX; Chen GT; Yang X; Wang YQ; Hong L
    Curr Med Sci; 2018 Apr; 38(2):212-221. PubMed ID: 30074178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
    Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
    Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of eukaryotic translation initiation factor 5A-1 (eIF5A-1) gene in HPV 16 E6 induces cell growth in human cervical squamous carcinoma cells.
    Liu Z; Teng L; Gao L; Wang H; Su Y; Li J
    Biochem Biophys Res Commun; 2018 Sep; 504(1):6-12. PubMed ID: 30170728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1.
    Tyagi A; Vishnoi K; Mahata S; Verma G; Srivastava Y; Masaldan S; Roy BG; Bharti AC; Das BC
    Clin Cancer Res; 2016 Aug; 22(16):4170-84. PubMed ID: 26988248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
    Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition.
    Nie G; Tang B; Lv M; Li D; Li T; Ou R; Xu Y; Wen J
    Cell Biol Int; 2023 Aug; 47(8):1327-1343. PubMed ID: 37191290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.
    López J; Poitevin A; Mendoza-Martínez V; Pérez-Plasencia C; García-Carrancá A
    BMC Cancer; 2012 Jan; 12():48. PubMed ID: 22284662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
    Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
    Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.